Navigation Links
Complete Genomics Announces Its First Public Presentation at the 7th Annual BIO Investor Forum
Date:10/22/2008

MOUNTAIN VIEW, Calif., Oct. 22 /PRNewswire/ -- Complete Genomics Inc., a newly launched, third-generation human genome sequencing company, today announced the company's presentation at the 7th Annual BIO Investor Forum, which will be held in San Francisco, Oct. 29-31, 2008.

Dr. Clifford Reid, chairman, president and chief executive officer of Complete Genomics, will present on Wednesday, Oct. 29, at 2:45 p.m. in the Marina Room of the Palace Hotel, located at 2 New Montgomery Street in downtown San Francisco. He will discuss how Complete Genomics' scalable service model and proprietary technology advances will allow the company to introduce its sequencing service in Q2 2009 at a cost of $5,000 per genome.

About Complete Genomics

Founded in 2006, Complete Genomics is a California company that has developed a novel approach to sequencing human DNA. Complete Genomics plans to combine its proprietary third-generation DNA sequencing technology and its high-performance computing capabilities to create a human genome sequencing service that will deliver low-cost, high-quality data on an unprecedented scale. The company is currently building the world's largest human genome sequencing center. This development will allow pharmaceutical and biotechnology customers, for the first time, to conduct large-scale human genome studies that will help identify the genetic underpinnings of complex diseases and drug responses. For additional information about the company, please visit http://www.completegenomics.com.


'/>"/>
SOURCE Complete Genomics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. American Oriental Bioengineering Completes Two Acquisitions
2. Acasti Pharma completes offer to exchange outstanding Neptune Technologies dividend notes
3. Peregrine Pharmaceuticals Completes Patient Enrollment In First Stage of Bavituximab Phase II Lung Cancer Trial
4. S*BIO Completes US$26 Million Equity Financing
5. Shengtai Pharmaceutical Completes Factory Improvements Resulting in Operational and Environmental Benefits
6. CeNeRx BioPharma Completes $15 Million Series B Financing
7. eRT Completes Milestone 100th Thorough QT Study
8. Neptune Technologies successfully completes $2.75 million private placement with 10% management participation
9. Oncolytics Biotech Inc. Completes Initial Scale Up of Manufacturing Process for REOLYSIN(R) to Commercial Scale
10. Facet Solutions Completes Facet Joint and Disc Replacement Study
11. Complete Genomics Launches, Becomes Worlds First Large-Scale Human Genome Sequencing Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 This report analyzes the worldwide markets for ... (Humic, Amino, & Fulvic), Extract Based, and Others. The report ... Ornamental & Turf, Row Crops, and Others. The report provides ... , Japan , Europe ... , and Rest of World. Annual estimates and forecasts ...
(Date:12/8/2016)... ... December 08, 2016 , ... From ... innovation is taking over sports. On Thursday, December 15th a panel of entrepreneurs, ... disrupting the playing field at a Smart Talk session. Smart Talk will run ...
(Date:12/8/2016)... DIEGO , Dec. 8, 2016  Renova™ ... for congestive heart failure and type 2 diabetes, ... for a novel adeno-associated virus (AAV) vector developed ... , M.D., Ph.D., at Stanford University. The company ... its paracrine gene therapy product pipeline. ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... SDK that provide essential device-to-computer interconnect using USB or PCI Express, announced the ... support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits a standard ...
Breaking Biology Technology:
(Date:12/7/2016)... 7, 2016 BioCatch , the global leader ... patent portfolio, which grew to over 40 granted and pending patents. ... , , ... entitled " System, Device, and Method Estimating Force Applied to ... makers to forego costly hardware components needed to estimate the force and ...
(Date:12/6/2016)... Valencell , the leading innovator in performance biometric ... consecutive year of triple digit growth for its PerformTek ... 360 percent increase in companies who have acquired Valencell ... sales of its wrist and ear Benchmark™ sensor systems, ... hearables for fitness and healthcare applications. ...
(Date:12/2/2016)... , Dec. 1, 2016   SoftServe , ... BioLock , an electrocardiogram (ECG) biosensor analysis ... a key IoT asset. The smart system ensures ... vehicle,s steering wheel and mobile devices to easily ... As vehicle technology advances, so too ...
Breaking Biology News(10 mins):